New drug might halt the progress of neurodegenerative disease
The first trial for the drug included 20 children. Although it was initially meant as just a safety test, researchers report that the drug improved patients' motor function, enabled them to achieve motor milestones, and improved the functioning of the nerves that are normally attacked by the disease.
Kommentar